Clinical trial
Williams Syndrome SHAAPE STUDY [Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study]
NCT03758651 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Williams Syndrome SHAAPE STUDY [Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study]
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- September 14, 2023
- Enrollment
- 144 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.